SME Times is powered by   
Search News
Just in:   • India-Italy ties set on path of rapid expansion: Italian President  • Sensex, Nifty end higher as India-EU trade deal boosts sentiment  • India, EU FTA brings big relief on car tariffs as import duties reduced to 10 pc from 110 pc  • 'Milestone in India-EU Strategic Partnership': PM Modi, EU leadership hail historic FTA deal  • Over 99 pc of Indian goods gain preferential entry into EU, $75 billion worth exports to take off 
Last updated: 12 Mar, 2025  

pharma1.jpg India ranked 11th in global pharma exports in 2023: Centre

pharma1.jpg
   Top Stories
» Sensex, Nifty end higher as India-EU trade deal boosts sentiment
» EU trade deal biggest in India's history, to create huge opportunities: PM Modi
» PM Modi inaugurates IEW 2026; announces 'significant' India-EU trade development
» Sensex, Nifty open lower as investors await India-EU FTA
» India, EU set to announce ‘mother of all trade deals’
IANS | 12 Mar, 2025

With the government taking several measures to ensure the quality, safety and efficacy of medicines, the Indian pharmaceutical exports ranked 11th globally in value terms in the year 2023, Anupriya Patel, Union Minister of State for Chemicals and Fertilisers, said in the Rajya Sabha on Tuesday.

Citing a research analysis published by Bain and Company in the year 2025, Patel said that the total pharmaceutical exports accounted for 3 per cent.

“The Central Drugs Standard Control Organisation (CDSCO) and the Ministry of Health and Family Welfare have taken several measures to ensure the quality, safety, and efficacy of medicines,” Patel said, in a written reply.

This includes risk-based inspections of drug manufacturing and testing firms in December 2022 by the CDSCO, in collaboration with State regulators.

About “905 units have been inspected, resulting in 694 actions being taken,” the minister added.

Meanwhile, the MoS also stated that the National Pharmaceuticals Pricing Policy (NPPP), 2012 has laid down principles for the regulation of prices of drugs.

“The key principles of regulation of prices under the said policy are -- regulation on the basis of essentiality of drugs, regulation of prices of formulations only, that is, medicines used by consumers and not the upstream products such as bulk drugs or intermediates, and regulation through market-based pricing and not cost-based pricing,” Patel said.

Under the policy, the National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals (DoP), fixes ceiling prices under the provisions of the Drugs (Prices Control) Order (DPCO), 2013.

For consumer benefit and transparency, the Ministry has also launched NPPA’s mobile app, Pharma Sahi Daam (PSD). It is available for download from the Google Playstore for Android-based devices and from App Store for Apple devices.

Consumers can easily access the brand name, composition, ceiling price, and maximum retail price of drugs from PSD.

Further, all price notifications of formulations for which prices have been fixed or revised are available on NPPA’s website, Patel said.

 
Print the Page
Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
₹91.2
₹89.5
UK Pound
₹123.35
₹119.35
Euro
₹107
₹103.35
Japanese Yen ₹57.9 ₹56.1
As on 22 Jan, 2026
  Daily Poll
Will the India-EU "Mother of All Deals" help your MSME?
 Yes - Alternative To US
 No - EU Compliance is hard
 Maybe - if the fine print is small biz ready
 Not Sure - Need to See Final Text
  Commented Stories
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter